Next Generation Cardiometabolic Diagnostics

Zora Biosciences Oy is a diagnostic company with a cardiometabolic focus.

We use mass spectrometry to identify markers of disease and develop them into robust, high-throughput, value-added clinical diagnostic tests which are commercialized together with our international partners or through our own reference laboratory in Finland.

Read more about Zora

Our Diagnostic Tests

1) Heart disease: CERT2 - Ceramide-based cardiovascular risk score for assessing risk of myocardial infarction, cardiovascular death and stroke

2) Type 2 Diabetes: dSCORE - Ceramide-based risk score for the probability of type II diabetes onset

3) Fatty Liver Disease: In development

28.11.2025

Learn how Mayo Clinic uses CERT-test

Ceramides score is reproducible and modifiable with lifestyle interventions and medications that lower cholesterol; it also helps with tracking patient progress and motivation.

Read more

Zora publications

Please check our latest publications including our research on coronary event risk. The publications can be found from News - Publications.

Publications